Abstract
Asylum seekers are screened for tuberculosis at entry to Norway. We aimed to assess follow-up of screening results at different healthcare levels in relation to demographics, screening results and organizational factors, and how this influenced treatment of latent tuberculosis. All asylum seekers >or=18 years with a Mantoux test >or=6 mm or positive x-ray findings who arrived at the National Reception Centre from January 2005 to June 2006, were included. Data were collected from public health authorities in the municipality where the asylum seekers had moved, and from internists in case they had been referred to a specialist. Specialists are responsible for treating latent tuberculosis. Individual subjects were matched with the National Tuberculosis Register to which everybody who had started treatment for latent tuberculosis was reported. Of 4,643 asylum seekers, 2,237 fulfilled the inclusion criteria. By May 2008, 30 persons had started treatment for latent TB, a median of 17 months (range 3-36) after arrival. A Mantoux test >or=15 mm on arrival was significantly associated with treatment. Demographic factors influenced follow-up in primary healthcare while screening results did not. Referral to specialist was related to scre...Continue Reading
References
May 10, 2002·The European Respiratory Journal·J F BroekmansUNKNOWN World Health Organization, International Union Against Tuberculosis and Lung Disease, and Royal Netherlands Tuberculosis Ass
Jul 5, 2003·Journal of Clinical Microbiology·Ulf R DahleDominique A Caugant
Jun 9, 2005·JAMA : the Journal of the American Medical Association·Young Ae KangJae-Joon Yim
Oct 21, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Wing Wai Yew, Chi Chiu Leung
May 16, 2008·BMC Infectious Diseases·Brita Askeland WinjeEinar Heldal
May 16, 2009·BMC Public Health·Ingunn HarstadGeir W Jacobsen
Citations
Nov 6, 2012·BMC Infectious Diseases·Apostolos SarivalasisPatrick Bodenmann
Nov 6, 2010·BMC Public Health·Ingunn HarstadHelge Garåsen
Jun 3, 2014·BMC Health Services Research·Ingunn HarstadEli Sagvik
Dec 18, 2014·BMC Infectious Diseases·Nadine Durema PullarAnne Ma Dyrhol-Riise
Apr 17, 2015·BMC Public Health·Bernardo R Guzman HerradorUlf R Dahle
May 16, 2009·BMC Public Health·Ingunn HarstadGeir W Jacobsen
Apr 12, 2011·PloS One·Hassan MahomedGregory D Hussey
Jun 11, 2015·PloS One·Florian M MarxWalter Haas
Nov 23, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·G J FoxJ T Denholm
Jan 14, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Ingunn Harstad, Geir W Jacobsen
Feb 17, 2018·Public Health Reviews·Andreas Halgreen Eiset, Christian Wejse
Mar 10, 2017·BMC Infectious Diseases·Peter AugusteAileen Clarke
Nov 21, 2018·BMC Infectious Diseases·Yvette Louise ScheinBrita Askeland Winje
Jan 14, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Reidun BrunvatneElda Furulund Borg
Aug 8, 2021·The Lancet Infectious Diseases·Kieran RustageUNKNOWN ESGITM and ESGMYC study groups